• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嵌合宿主中的复合组织同种异体移植:第一部分。移植物抗宿主病的预防。

Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease.

作者信息

Gorantla Vijay S, Prabhune Kaustubha A, Perez-Abadia Gustavo, Ildstad Suzanne T, Maldonado Claudio, Orhun Haldun I, Majzoub Ramsey K, Francois Cedric G, Kakoulidis Thanos P, Brouha Pascal C R, Anderson Gary L, Pidwell Diane J, Breidenbach Warren C, Barker John H

机构信息

Division of Plastic and Reconstructive Surgery, Plastic Surgery Research, University of Louisville, 511 South Floyd Street, Louisville, KY 40292, USA.

出版信息

Transplantation. 2003 Apr 15;75(7):922-32. doi: 10.1097/01.TP.0000058302.45424.03.

DOI:10.1097/01.TP.0000058302.45424.03
PMID:12698075
Abstract

BACKGROUND

Mixed allogeneic chimerism (MAC) has been shown to induce tolerance to composite tissue allografts (CTA). However, transplantation of unmanipulated donor-specific limbs results in severe graft-versus-host disease (GVHD). This suggests that nontolerant mature donor-derived cells in the CTA may affect the stability of chimerism, potentially resulting in GVHD. The aim of this study was to develop an approach to study and prevent GVHD in a mixed chimeric-rat hind-limb transplantation model.

METHODS

[ACI-->WF] chimeras received a limb from Wistar Furth (WF) (syngeneic), Fisher (third-party), or ACI (irradiated [1,050 cGy] or nonirradiated) rats. In vitro tolerance was assessed using mixed lymphocyte reactivity (MLR) assays at the time the animals were killed.

RESULTS

[ACI-->WF] chimeras with greater than 85% chimerism exhibited rejection-free survival of donor-specific hind limbs. However, 100% of these animals developed lethal GVHD 22.4+/-2.8 days after limb transplantation. [ACI-->WF] chimeras that underwent transplantation with irradiated ACI or syngeneic WF limbs showed no signs of rejection or GVHD at 5 months. Nonchimeric and third-party controls rejected limbs within 10 days.

CONCLUSIONS

Conditioning of the host WF rats with 950 cGy of irradiation (sublethal, myeloablative) led to high levels of MAC without GVHD. The mature T-cell content of nonirradiated donor (ACI) limbs was sufficient to induce lethal GVHD in 100% of tolerant mixed chimeric [ACI-->WF] hosts. Irradiation of donor limbs before transplantation resulted in long-term donor-specific tolerance and prevented GVHD. These data demonstrate that (1) established chimeras could be susceptible to GVHD caused by immunocompetent donor cells transferred with the hind limb, and (2) inactivating these cells with irradiation prevents GVHD and destabilization of chimerism, and permits rejection-free graft acceptance.

摘要

背景

混合异基因嵌合体(MAC)已被证明可诱导对复合组织同种异体移植物(CTA)的耐受。然而,移植未经处理的供体特异性肢体可导致严重的移植物抗宿主病(GVHD)。这表明CTA中未耐受的成熟供体来源细胞可能影响嵌合体的稳定性,从而可能导致GVHD。本研究的目的是开发一种方法,用于研究和预防混合嵌合大鼠后肢移植模型中的GVHD。

方法

[ACI→WF]嵌合体接受来自Wistar Furth(WF)(同基因)、Fisher(第三方)或ACI(照射[1,050 cGy]或未照射)大鼠的肢体。在处死动物时,使用混合淋巴细胞反应(MLR)试验评估体外耐受性。

结果

嵌合率大于85%的[ACI→WF]嵌合体表现出供体特异性后肢的无排斥存活。然而,这些动物中有100%在肢体移植后22.4±2.8天发生致命的GVHD。接受照射的ACI或同基因WF肢体移植的[ACI→WF]嵌合体在5个月时未出现排斥或GVHD迹象。非嵌合体和第三方对照在10天内排斥肢体。

结论

用950 cGy照射(亚致死性、骨髓清除性)处理宿主WF大鼠可导致高水平的MAC且无GVHD。未照射的供体(ACI)肢体中的成熟T细胞含量足以在100%耐受的混合嵌合[ACI→WF]宿主中诱导致命的GVHD。移植前照射供体肢体可导致长期的供体特异性耐受并预防GVHD。这些数据表明:(1)已建立的嵌合体可能易受与后肢一起转移的具有免疫活性的供体细胞引起的GVHD影响;(2)用照射使这些细胞失活可预防GVHD和嵌合体的不稳定,并允许无排斥地接受移植物。

相似文献

1
Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease.嵌合宿主中的复合组织同种异体移植:第一部分。移植物抗宿主病的预防。
Transplantation. 2003 Apr 15;75(7):922-32. doi: 10.1097/01.TP.0000058302.45424.03.
2
Lymphadenectomy prior to rat hind limb allotransplantation prevents graft-versus-host disease in chimeric hosts.
Transpl Int. 2004 Aug;17(7):341-50. doi: 10.1007/s00147-004-0724-5. Epub 2004 Jul 29.
3
Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.间充质干细胞增强骨髓移植后大鼠后肢同种异体移植物混合嵌合体的诱导和耐受。
J Surg Res. 2010 May 15;160(2):315-24. doi: 10.1016/j.jss.2008.09.027. Epub 2008 Nov 4.
4
Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.通过混合嵌合和CD28阻断实现复合组织同种异体移植的长期接受。
Transplantation. 2003 Sep 27;76(6):988-94. doi: 10.1097/01.TP.0000079827.91675.A3.
5
Composite tissue allotransplantation in chimeric hosts part II. A clinically relevant protocol to induce tolerance in a rat model.嵌合宿主中的复合组织同种异体移植 第二部分。在大鼠模型中诱导耐受的临床相关方案。
Transplantation. 2003 Dec 15;76(11):1548-55. doi: 10.1097/01.TP.0000085288.12571.65.
6
Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.大鼠中的混合异基因嵌合体。主要血管化心脏同种异体移植物的供体特异性移植耐受且无慢性排斥反应。
Transplantation. 1995 Nov 15;60(9):971-80.
7
Vascularized lymph node transplantation induces graft-versus-host disease in chimeric hosts.血管化淋巴结移植在嵌合宿主中诱发移植物抗宿主病。
Transplantation. 2006 May 27;81(10):1435-41. doi: 10.1097/01.tp.0000209210.75211.57.
8
Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.基于他克莫司的部分预处理可产生稳定的混合淋巴细胞造血嵌合体并诱导对心脏同种异体移植的耐受。
Circulation. 1998 Nov 10;98(19 Suppl):II163-8; discussion II168-9.
9
Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.通过非致死性预处理方案实现的混合嵌合体可诱导对肺同种异体移植物的供体特异性耐受。
J Surg Res. 2008 May 15;146(2):289-97. doi: 10.1016/j.jss.2007.07.017. Epub 2007 Aug 23.
10
Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.混合异体嵌合体作为跨越主要和次要组织相容性屏障诱导复合组织同种异体移植耐受的可靠模型。
Transplantation. 2001 Sep 15;72(5):791-7. doi: 10.1097/00007890-200109150-00009.

引用本文的文献

1
From Lab to Limb: Unraveling Translational Insights and Significance of Animal Models in Lower Extremity Transplantation.从实验室到临床应用:解读动物模型在下肢移植中的转化见解及意义
JPRAS Open. 2024 Nov 28;43:232-244. doi: 10.1016/j.jpra.2024.11.018. eCollection 2025 Mar.
2
Evolution of the rat hind limb transplant as an experimental model of vascularized composite allotransplantation: Approaches and advantages.大鼠后肢移植作为血管化复合异体移植实验模型的演变:方法与优势
SAGE Open Med. 2020 Oct 30;8:2050312120968721. doi: 10.1177/2050312120968721. eCollection 2020.
3
The need for inducing tolerance in vascularized composite allotransplantation.
在血管化复合组织异体移植中诱导免疫耐受的必要性。
Clin Dev Immunol. 2012;2012:438078. doi: 10.1155/2012/438078. Epub 2012 Oct 31.
4
Simultaneous bone marrow and composite tissue transplantation in rats treated with nonmyeloablative conditioning promotes tolerance.非清髓预处理大鼠同时进行骨髓和复合组织移植可促进免疫耐受。
Transplantation. 2013 Jan 27;95(2):301-8. doi: 10.1097/TP.0b013e31827899fc.
5
Improving the safety of tolerance induction: chimerism and cellular co-treatment strategies applied to vascularized composite allografts.提高免疫耐受诱导的安全性:应用于血管化复合组织异体移植的嵌合现象及细胞联合治疗策略
Clin Dev Immunol. 2012;2012:107901. doi: 10.1155/2012/107901. Epub 2012 Oct 22.
6
Science of composite tissue allotransplantation.复合组织同种异体移植科学。
Transplantation. 2008 Sep 15;86(5):627-35. doi: 10.1097/TP.0b013e318184ca6a.
7
Composite tissue transplantation: a rapidly advancing field.复合组织移植:一个快速发展的领域。
Transplant Proc. 2008 Jun;40(5):1237-48. doi: 10.1016/j.transproceed.2008.04.003.